Vamil Divan
Stock Analyst at Guggenheim
(2.64)
# 537
Out of 5,328 analysts
278
Total ratings
55.36%
Success rate
31.25%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ABBV AbbVie | Maintains: Strong Buy | 214 216 | 193.41 | 11.68% | 22 | Apr 29, 2025 | |
UNCY Unicycive Therapeuti... | Initiates Coverage On: Buy | 6 | 0.65 | 823.08% | 1 | Apr 21, 2025 | |
MRK Merck & Co | Reiterates: Buy | 115 115 | 83.31 | 38.04% | 9 | Apr 17, 2025 | |
TVTX Travere Therapeutics | Reiterates: Buy | 47 47 | 20.81 | 125.85% | 8 | Apr 14, 2025 | |
ANIP ANI Pharmaceuticals | Reiterates: Buy | 86 86 | 70.81 | 21.45% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 31 | 11.44 | 170.98% | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 3.04 | 228.95% | 3 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | n/a | n/a | n/a | 17 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 59 61 | 23.7 | 157.38% | 5 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 101 101 | 72.77 | 38.79% | 6 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 5 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 4 | n/a | n/a | 6 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 6 | 0.86 | 597.67% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 55 | n/a | n/a | 1 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 245 330 | n/a | n/a | 7 | Jan 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 19 20 | 7.5 | 166.67% | 9 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 21 18 | n/a | n/a | 2 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 26 | 0.35 | 7328.57% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 40 | n/a | n/a | 3 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 9 | 0.99 | 809.09% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 13 2 | n/a | n/a | 5 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 27 19 | 14.59 | 30.23% | 7 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 95 98 | 106.71 | -8.16% | 8 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 34 | 30.63 | 11% | 7 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 10 | 1.26 | 693.65% | 3 | May 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 51 49 | 112.47 | -56.43% | 3 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 315 356 | 794.79 | -55.21% | 15 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 6 | 4.49 | 33.63% | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 144 154 | 22.56 | 582.62% | 9 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 15 | 11.86 | 26.48% | 5 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 4 | n/a | n/a | 6 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 11 19 | n/a | n/a | 8 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 35 | n/a | n/a | 13 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | n/a | n/a | n/a | 13 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 36 30 | n/a | n/a | 4 | May 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 161 155 | n/a | n/a | 10 | Mar 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 15 | 3.51 | 327.35% | 4 | Aug 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 58 61 | 49.49 | 23.26% | 5 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 103 | 0.98 | 10410.2% | 3 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 55 | n/a | n/a | 1 | Sep 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 66 120 | n/a | n/a | 4 | Dec 20, 2016 |